Advanced glycation end products in diabetic corneas

被引:3
|
作者
Kaji, Y
Usui, T
Oshika, T
Matsubara, M
Yamashita, H
Araie, M
Murata, T
Ishibashi, T
Nagai, R
Horiuchi, S
Amano, S
机构
[1] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Kyushu Univ, Sch Med, Dept Ophthalmol, Fukuoka 812, Japan
[3] Kumamoto Univ, Sch Med, Dept Biochem, Kumamoto 860, Japan
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Corneal complications are often associated with diabetes mellitus and can be vision threatening. Corneas in diabetic patients are exposed to increased glucose concentration despite cornea's avascular property, and this condition may contribute to the accumulation of advanced glycation end products (AGEs). The focus of this study was to examine the rule of AGEs ill the pathogenesis of diabetic keratopathy. METHODS. An anti-AGE monoclonal antibody (6D12), which recognizes a N-epsilon-carboxymethyl lysine (CML)-protein adduct as an epitope, was prepared. Immunohistochemical localization of CML was examined in human age-matched diabetic and nondiabetic corneas (8 of each). In vitro, type I collagen-, type IV collagen-, or laminin-coated 90-well plates were glycated by glucose-6-phosphate. In some experiments, aminoguanidine was present in the incubation mixture. The amounts of CML-protein adducts in the extracellular matrix (ECM) were determined by enzyme-linked immunosorbent assay using 6D12. SV40-immortalized human corneal epithelial cells were seeded onto modified or unmodified ECM in 96-well plates and allowed to attach for 3 hours. Attached cells were fixed, and the areas of attached cells in each condition were measured. Attached cells without fixation were removed, and cell number was counted. RESULTS. In all of the 8 diabetic corneas, CML immunoreactivity was observed in the epithelial basement membrane, whereas CML immunoreactivity was not found in the corresponding area in of 8 nondiabetic corneas. In vitro, nonenzymatic glycation of laminin on the culture dish attenuated adhesion and spreading of corneal epithelial cells. The presence of aminoguanidine in the incubation mixture during glycation inhibited CML formation and promoted the adhesion and spreading of corneal epithelial cells in a dose-dependent manner. CONCLUSIONS. The accumulation of AGEs on the basement membrane, particularly on laminin, may play a causative role in the corneal epithelial disorders of diabetic patients.
引用
下载
收藏
页码:362 / 368
页数:7
相关论文
共 50 条
  • [21] Advanced glycation end products, oxidative stress and diabetic nephropathy
    Yamagishi, Sho-ichi
    Matsui, Takanori
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2010, 3 (02) : 101 - 108
  • [22] The Role of Advanced Glycation End Products in Diabetic Vascular Complications
    Rhee, Sang Youl
    Kim, Young Seol
    DIABETES & METABOLISM JOURNAL, 2018, 42 (03) : 188 - 195
  • [23] THE ROLE OF ADVANCED GLYCATION END PRODUCTS IN PATOGENESIS OF DIABETIC NEPHROPATHY
    Gavrilova, Alina O.
    Severina, Anastasia S.
    Shamhalova, Minara S.
    Shestakova, Marina, V
    DIABETES MELLITUS, 2021, 24 (05): : 461 - 469
  • [24] Advanced glycation end products in diabetic cardiomyopathy: An alternative hypothesis
    Bowman, Marion A. Hofmann
    Fedson, Savitri
    Schmidt, Ann Marie
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (11): : 1303 - 1303
  • [25] Advanced glycation end products: role in pathology of diabetic cardiomyopathy
    Bodiga, Vijaya Lakshmi
    Eda, Sasidhar Reddy
    Bodiga, Sreedhar
    HEART FAILURE REVIEWS, 2014, 19 (01) : 49 - 63
  • [26] Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
    Jing-Xu
    Chen, Lin-Jiang
    Yu, Jian
    Wang, Han-Jing
    Zhang, Fan
    Liu, Qiong
    Wu, Jing
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (02) : 705 - 717
  • [27] Advanced glycation end products in human diabetic lens capsules
    Rankenberg, Johanna
    Rakete, Stefan
    Wagner, Brandie D.
    Patnaik, Jennifer L.
    Henning, Christian
    Lynch, Anne
    Glomb, Marcus A.
    Nagaraj, Ram H.
    EXPERIMENTAL EYE RESEARCH, 2021, 210
  • [28] Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications
    Yamagishi, Sho-ichi
    Nakamura, Kazuo
    Imaizumi, Tsutomu
    CURRENT DIABETES REVIEWS, 2005, 1 (01) : 93 - 106
  • [29] Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
    Oshitari, Toshiyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [30] Involvement of advanced glycation end products in complications of diabetic patients
    Guillet, Christelle
    NUTRITION CLINIQUE ET METABOLISME, 2010, 24 (03): : 109 - 114